about
Platelet aggregation and quality control of platelet concentrates produced in the Amazon Blood BankPlatelets: still a therapeutical target for haemostatic disorders.Recombinant activated factor VII (NovoSeven): addition to replacement therapy in acute, uncontrolled and life-threatening bleeding.Immune tolerance therapy in patients with acquired hemophilia.Quantification of platelets obtained by different centrifugation protocols in SHR rats.Recombinant factor VIIa: a general hemostatic agent? Yes.
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
To general haemostasis--the evidence-based route.
@ast
To general haemostasis--the evidence-based route.
@en
type
label
To general haemostasis--the evidence-based route.
@ast
To general haemostasis--the evidence-based route.
@en
prefLabel
To general haemostasis--the evidence-based route.
@ast
To general haemostasis--the evidence-based route.
@en
P356
P1476
To general haemostasis--the evidence-based route.
@en
P2093
Elisabeth Erhardtsen
P356
10.1159/000057302
P478
32 Suppl 1
P577
2002-01-01T00:00:00Z